Computer Modeling Assisted Design of Monodisperse PLGA Microspheres with Controlled Porosity Affords Zero Order Release of an Encapsulated Macromolecule for 3 Months

Files

Access status: Embargo until 2050-01-01 , 8.pdf (2.31 MB)

Publication date

2014-05-14

Authors

Kazazi, F.ISNI 0000000396247130
Landin, Mariana
Lathuile, Audrey
Veldhuis, Gert J.
Rahimian, SimaISNI 0000000507301188
Hennink, W.E.ISNI 0000000390382745
Kok, Robbert JanORCID 0000-0003-4933-3968ISNI 0000000392754805
Van Nostrum, Cornelus F.ISNI 0000000396379707

Editors

Advisors

Supervisors

Document Type

Article

License

Abstract

Purpose The aim of this study was the development of poly(D,L-lactide-co-glycolide) (PLGA) microspheres with controlled porosity, to obtain microspheres that afford continuous release of a macromolecular model compound (blue dextran). Methods PLGA microspheres with a size of around 40 μm and narrow size distribution (span value of 0.3) were prepared with a double emulsion membrane emulsification method. Gene expression programming (GEP) analysis was applied to design and formulate a batch of microspheres with controlled porosity that shows continuous release of blue dextran. Results Low porous microspheres with a high loading efficiency were formed at high polymer concentrations (30% w/w in the oil phase) and were characterized with a burst release <10% and a three-phasic release profile of blue dextran. Increasing porosity (10% w/w polymer concentrations), a sustained release of blue dextran was obtained albeit with up to 40% of burst release. The desired formulation, calculated by GEP, resulted in microspheres with 72% loading efficiency and intermediate porosity. Blue dextran was indeed released continuously in almost a zero order manner over a period of 3 months after an initial small burst release of 9%. Conclusions By fine-tuning the porosity, the release profile of PLGA microspheres for macromolecules can be predicted and changed from a three-phasic to a continuous release.

Keywords

controlled release, membrane emulsification, microspheres, PLGA, porosity, Pharmacology, Biotechnology, Pharmacology (medical), Molecular Medicine, Organic Chemistry, Pharmaceutical Science

Citation

Kazazi-Hyseni, F, Landin, M, Lathuile, A, Veldhuis, G J, Rahimian, S, Hennink, W E, Kok, R J & van Nostrum, C F 2014, 'Computer Modeling Assisted Design of Monodisperse PLGA Microspheres with Controlled Porosity Affords Zero Order Release of an Encapsulated Macromolecule for 3 Months', Pharmaceutical Research, vol. 31, no. 10, pp. 2844-2856. https://doi.org/10.1007/s11095-014-1381-8